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ABSTRACT 
 
Wastewater treatment plants (WWTP) are typically incapable of addressing the 
influx of antibiotics (AB), and may act as a harbor for the selection and proliferation of 
antibiotic resistant bacteria (ARB). In order to examine the influence of WWTP 
discharge on the AB resistance profiles of surface water bacteria in an urban stream 
setting, E. coli isolates and total heterotrophic bacteria populations were cultivated from 
6 sampling sites up and downstream of WWTPs, and evaluated for resistance to selected 
ABs. Samples were collected over a 9-month period in the Carter’s Creek watershed of 
College Station, TX. E. coli isolates were tested for resistance to ampicillin, tetracycline, 
sulfamethoxazole, ciprofloxacin, cephalothin, cefoperazone, gentamycin, and imipenem 
using the Kirby-Bauer disc diffusion method. HPCs were cultivated on R2A amended 
with ampicillin, ciprofloxacin, tetracycline, and sulfamethoxazole. Significant 
associations (p < 0.05) were observed between the locations of sampling sites relative to 
WWTP discharge points and the rate of E. coli isolate resistance to tetracycline, 
ampicillin, cefoperazone, ciprofloxacin, and sulfamethoxazole; and an increased rate of 
isolate multi-drug resistance. The abundance of AB-resistant HPCs was significantly 
greater (p < 0.05) downstream of WWTPs for all treatments; however, there was no 
spatially significant difference when normalized to total HPCs cultivated with no AB. 
Results suggest that the effects of human development, specifically the discharge of 
treated WWTP effluent into surface waters, are potentially significant contributors to the 
spread and persistence of AB resistance in the surrounding watershed. 
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1. INTRODUCTION  
 
1.1 Antibiotic Resistance 
The development of antibiotics led to historically groundbreaking advancements 
in public health. Through the first 8 decades of the 20th century, the infectious disease 
mortality rate was reduced by 95% (Armstrong et al., 1999). Surgical infection rates 
were reduced from 40% to 2% (Zaffiri et al., 2012). As the prevalence of antibiotic use 
has increased in modern society due to their effectiveness and impact in mitigating 
bacterial health risks, so has the occurrence of bacteria developing resistance to widely 
used antibiotics. The rates of antibiotic resistance in pathogenic bacteria have been 
increasing rapidly over the last several decades (Jones et al., 2008), and the occurrence 
of antibiotic resistance has been identified as a critical issue by the U.S. Center for 
Disease Control (CDC), World Health Organization (WHO), and numerous other global 
authorities in public health (Pruden, 2014).  
Resistance traits in bacteria can propagate by gene transfer of antibiotic 
resistance genes (ARGs) between organisms and by spontaneous mutational changes 
that alter the interactions between the target and antibiotic agent within the cell (Pepper 
et al., 2015). Horizontal gene transfer between organisms can occur through conjugation, 
the direct cell-to-cell transfer of plasmid DNA through the extension of a pilus; 
transduction, the transfer of genetic information through bacteriophages; and 
transformation, the uptake of free DNA from the cell’s environment (Pepper & Gentry, 
2015). Conjugation is thought to be the most common method of transfer of ARGs in 
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environments with high cell counts (Courvalin, 1994, Pepper & Gentry, 2015), and 
allows for the transfer of genetic material between unrelated species (Davison, 1999), 
meaning that ARGs in nonpathogenic organisms can be transferred to pathogens. In the 
presence of antibiotics, selective pressure is placed on microbial communities, 
encouraging the proliferation of organisms that possess resistance traits (Baquero et al., 
2008).  
Newly utilized antibiotics have generally seen a significant decrease in their 
effectivity within ten years of their development (Palumbi, 2001), and the rate of 
discovery of new antibiotics is decreasing while the emergence of resistance traits in 
bacteria continues to grow in tandem with increasing populations and antibiotic use 
(Pruden, 2014). There is also indication that bacterial resistance to specific antibiotics 
will stabilize and persist in the environment even after discontinued use of that antibiotic 
(Andersson, 2003), as the mechanisms that enable resistance promote additional 
environmental resilience and minimize survival costs of the organism (Levy & Marshall, 
2004). 
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1.2 Multidrug Resistance 
The proliferation of multi-drug resistant microbes and their corresponding impact 
on morbidity and mortality rates related to infections has been identified as a major 
threat to US public health and national security by the National Academy of Science’s 
Institute of Medicine, the federal Interagency Task Force on Antimicrobial Resistance, 
and the Infectious Diseases Society of America (IDSA) (Spellberg et al., 2008). Multi-
drug resistant Gram-negative bacterial infections have been reported to increase the 
length of hospital stays (Blot et al., 2010, Lye et al., 2012), limit the efficacy of entire 
regiments of antibiotic classes (Rice, 2006), and generally increase the need for novel  
mechanisms and antibacterial agents for treatment (Chopra et al., 2008, Nikaido & 
Pagès, 2012, Naqvi et al., 2013, Worthington & Melander, 2013).  
Multi-drug resistance is still a loosely defined term, with little consensus on the 
specific definitions of ‘multi-‘,’extreme-‘,’extensive-‘, or ‘pan-‘ drug resistance; 
definitions are formed based on relevance to the environment they are describing, 
making reliable reference between surveillance studies difficult  (Magiorakos et al., 
2012). It generally develops as a combination of different resistance mechanisms, 
utilizing limited outer-membrane permeability and efflux pumps to resist and remove 
antimicrobial agents from the cell before they have a chance to achieve an actionable 
concentration (Tenover, 2006). Mitigation of the development multi-drug resistance 
generally focuses on preventing the generation of environments that expose diverse 
microbial populations to sub-lethal concentrations of broad-spectrum antimicrobial 
agents (Dzidic & Bedeković, 2003). 
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1.3 Environmental Conveyance  
Major contributors to the spread of antibiotic resistance include excessive use in 
humans and animals, overcrowding and increased rates of transmission between people 
in communities and hospitals, and the failure of implementing and executing proper 
hygiene and disinfection practices (Gopal Rao, 2012). While the mechanisms by which 
ARBs and ARGs are transported and spread through the environment are still being 
researched, significant connections have been established between human activity and 
the conveyance of resistance traits through agricultural operations, aquatic environments, 
and sediments (Pei et al., 2006, Baquero et al., 2008).  
1.3.1 Agricultural Operations 
Non-point source introduction of resistant bacteria has largely been attributed to 
the application of antibiotics to feedlot operations, for use in the treatment of infections, 
disease prevention, and as a prophylactic to increase biological rates of production 
(Brooks et al., 2015). The subsequent land application of the manure/litter from the 
feedlots is then washed downstream into the watershed during rainfall events (Gunther et 
al., 1984). The occurrence of a number of AB resistant pathogens have been observed in 
connection to the extensive use of ciprofloxacin in poultry operations (Humphrey et al., 
2005), sparking concerns of foodborne conveyance and infection of the resistant bacteria 
(Pepper et al., 2015). Bacterial resistance to penicillin, cephalosporin, and tetracycline 
has been found in swine lagoon effluent, with increased multi-drug resistance found in 
nurseries with younger piglets (Brooks & McLaughlin, 2009). Chee-Sanford et al. 
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(2001) demonstrated that swine lagoon effluent could directly contribute to ARGs in soil 
and groundwater.   
1.3.2 Wastewater Treatment Plants 
Pharmaceutical compounds and resistant bacteria may also be introduced to 
wastewater treatment systems through hospital, industrial, and residential wastewater 
discharge, and then introduced to the environment (Zuccato et al., 2010, Amador et al., 
2015, Verlicchi et al., 2015). In terms of point-source inputs, wastewater treatment 
plants (WWTP) represent perhaps the most significant impact of human activity and 
urbanization on the surrounding watershed. Contemporary municipal WWTPs are 
typically incapable of specifically addressing the influx of antibiotics (Adams et al., 
2002), and may produce an environment where bacteria in the wastewater interact with 
relatively high concentrations of antibiotics. WWTP sludge has been suspected to foster 
an ideal environment for the exchange and development of resistant genes, providing 
additional advantages not available to microbes in the natural environment (Nicholls, 
2003). Treatment plants and the associated urbanization may act as a harbor for the 
selection process of resistant bacteria and resistance genes to eventually be introduced 
back into the aquatic environment (Makowska et al., 2016). 
Investigation into the contribution of wastewater treatment plants to resistance in 
the environment has expanded greatly in the past decade. Wastewater treatment has been 
found to be generally ineffective against certain strains of resistant enterococci, 
specifically with resistance to ciprofloxacin, erythromycin, and tetracycline  (da Silva et 
al., 2006), with the prevalence of ciprofloxacin resistance actually increasing through the 
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treatment process. The presence of sulfonamide resistance genes in a river environment 
was found to increase significantly downstream of a swine feedlot WWTP (Hsu et al., 
2014). Iwane et al. (2001) found that Escherichia coli isolates obtained along the Tama 
River in Tokyo, Japan expressed increasing resistance to antibiotic agents as sampling 
moved downstream, and was attributed to treatment plant discharge. Studies tend to vary 
with respect to the efficiency in which resistant organisms are removed during the 
treatment process, the microbial species expressing resistance in the effluent, and the 
antimicrobial agents to which the organisms express resistance (Sayah et al., 2005, 
Janezic et al., 2013).  
The confluence of antibiotics and resistant bacteria in WWTPs has also given 
rise to the concern of microbes developing resistance to multiple drugs. WWTPs may 
foster an environment that enables rapid exchange of genetic material through the 
microbial community, facilitating the sharing of ARGs and increasing rates of multi-
drug resistance in bacteria. Czekalski et al. (2012) found that while WWTPs reduced 
total bacterial loads in the effluent, there was an observed increase in multidrug resistant 
bacteria and ARGs which were then found to accumulate in the sediment of the plant 
outlet. Aeromonas and Pseudomonas aeruginosa isolates obtained from some water 
reservoirs were found to express 50 and 100% multi-drug resistance, respectively 
(Blasco et al., 2008). One potential culprit in the exchange of ARGs in WWTPs is the 
activated sludge comprising an integral part of most treatment processes (Wellington et 
al., 2013). One study suggested that sewage sludge may be a main reservoir for 
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fluoroquinolone residues, found to persist in the environment if transferred in the 
absence of adequate sludge management practices (Golet et al., 2003). 
Furthering the understanding of the impact urbanization and wastewater effluent 
has on the presence of antibiotic resistance in the environment will aid in future efforts 
to address antibiotic resistance through treatment plant process design. Current 
knowledge of how to directly treat wastewater for resistant bacteria and the effect of 
current treatment processes on resistant bacteria is very limited. Studies have been 
conducted to improve our understanding of current processes and to investigate new 
possible solutions, including ozonation, charcoal/sand filtration, and nanotechnology 
(Lüddeke et al., 2015, Sharma et al., 2015).  
1.3.3 Natural Environments 
Antibiotic resistance also occurs naturally in the environment, and is not solely a 
product of modern antibiotic use. Genes coding for resistance to tetracycline and 
vancomycin have been found frozen in 30,000 year old permafrost samples (D'Costa et 
al., 2011), and antibiotics have been active agents in the microbial community dating 
back to the emergence of vertebrate fish (Allen et al., 2010). Streptomyces isolates 
obtained from diverse urban, agricultural, and forest soils were found to be, without 
exception, resistant to at least 6 different antibiotics (D'Costa et al., 2006), indicating 
that soils likely act as a natural source for antibiotic resistance. While anthropogenic 
effects may be contributing to the selective propagation of antibiotic resistance in the 
environment, the resistance profiles of any natural setting will always be determined in 
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part by the characteristics of the indigenous microbial community (Wellington et al., 
2013).  
1.4 Study Goals 
This study aims to investigate the relationship between urban development and 
the occurrence and persistence of antibiotic resistance in the surrounding aquatic 
environment using bacterial resistance data produced by cultivation-based methods. In 
order to characterize the antimicrobial resistance profile of surface water bacteria in an 
urban stream setting, E. coli isolates and total heterotrophic bacteria populations were 
cultivated from six sampling sites within the Carter’s Creek watershed of Bryan/College 
Station (B/CS), TX, and evaluated for resistance to selected antibiotics. Sites were 
selected based on their relative location to local WWTP effluents in the watershed, and 
the position up and downstream of developed urban areas. Rates of antibiotic resistance 
for E. coli isolates and heterotrophic communities were compared by sampling site and 
their relative position with respect to WWTPs to determine if WWTP discharge may 
affect the antibiotic resistance profiles of surface water bacteria in the surrounding 
environment.  
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2. MATERIALS AND METHODS 
 
2.1 Study Area 
Six sampling sites were established within the boundaries of the Carter’s Creek 
watershed (Figure 1) in B/CS on the main stems of Carter’s Creek and Burton Creek. 
Sites were selected to represent areas both up and downstream of the more heavily 
developed areas of the Carter’s Creek watershed, and up and downstream of two 
WWTPs. Sites 1, 3, 5, and 6 were located on the main stem of Carter’s Creek, and sites 2 
and 4 located on the main stem of Burton Creek. Most sites (all but site 3) were located 
at the intersection of the respective creek and an overpassing bridge. Sites 2, 4, 5, and 6 
were sampled upstream of the bridge crossing, and site 1 was sampled directly 
underneath the overpass. Site 3 was sampled on the stream stem of Carter’s Creek 
running adjacent to the highway, upstream of its confluence with Burton Creek. Site 2 
was located at the outlet of a channelized stretch of Burton Creek, characterized by 
shallow flow with substantial algal growth on the concrete surface. All of the sampling 
sites selected in this study have been regular water quality monitoring sites for the Texas 
Commission on Environmental Quality (TCEQ) since the commencement of an ongoing 
Carter’s Creek watershed Total Maximum Daily Load (TMDL) project in August, 2007. 
Specific information concerning the sampling sites is included in Table 1.  
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Figure 1: Map of the Carter’s Creek watershed and locations of the six sampling sites and the two 
WWTPs 
 
 
 
Site selection was considerably driven by relative location to WWTP effluents. 
There are two major WWTPs operating and discharging effluent to the Carter’s Creek 
watershed: the Burton Creek Wastewater Treatment Facility (BCWWTF) and the 
Carter’s Creek Wastewater Treatment Plant (CCWWTP). The larger of the two plants, 
the CCWWTP, began operation in 1956 and now operates at a capacity of approximately 
35 million liters (9.5 million gallons) per day. The BCWWTF, commissioned in 1987, is 
authorized for a maximum discharge of 30 million liters (8 million gallons) per day, and 
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discharges into an unnamed tributary approximately 1,000 meters upstream of Burton 
Creek’s outlet into Carter’s Creek (TCEQ, 2006). Sites 1, 2, and 3 were located 
upstream of any WWTP discharge points, while sites 4, 5, and 6 were located 
downstream of at least one. Sites 4 and 5 were located downstream of one WWTP, the 
Burton Creek Wastewater Treatment Facility, and Site 6 was located downstream of 
both the Burton Creek and Carter’s Creek treatment facilities. There is a third WWTP 
servicing the southern area of College Station, discharging its effluent into Lick Creek. 
However, flows from Lick Creek do not interact with waters from the Carter’s Creek 
watershed until both creeks have converged with the Navasota River on their western 
borders.  
 
 
Table 1: Site locations and coordinates 
Site 
Number 
Description Coordinates 
Position in relation to 
WWTP 
1 
Carter's Creek at 
Briarcrest Drive 
30°40'04.3"N 
96°19'13.2"W 
Upstream 2 
Burton Creek at 
Tanglewood Drive 
30°38'26.8"N 
96°20'06.6"W 
3 
Carter's Creek upstream 
of Burton Creek 
30°38'40.3"N 
96°18'43.2"W 
4 
Burton Creek at Route 6, 
downstream of WWTP 
30°38'39.2"N 
96°18'50.4"W 
Downstream 5 
Carter's Creek at Harvey 
Road 
30°38'09.5"N 
96°17'45.2"W 
6 
Carter's Creek at Bird 
Pond Road 
30°36'10.6"N 
96°15'00.1"W 
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2.2 Sample Collection 
A total of six separate sampling events were conducted over a 9-month period 
between July, 2015 and April, 2016. Surface water samples were collected using ~500 
mL Whirl-Pak® sterile bags (eNasco, Fort Atkinson, WI) and a sampling pole. Water 
samples were collected from the mid-point of the stream flow approximately 3 cm below 
the surface. Samples were put on ice for transfer back to the laboratory and processed 
within 6 hours of collection. E. coli isolates were collected for antibiotic susceptibility 
testing from 5 of the 6 sampling events. Heterotrophic plate counts were obtained for all 
6 sampling events.   
2.3 E. coli Isolation and Antibiotic Susceptibility Testing by Kirby-Bauer Disc 
Diffusion Method 
Four concentrations of each sample were prepared (1.0, 0.1, 0.01, and 0.001) by 
ten-fold serial dilutions in phosphate-buffered saline solution (PBS). Ten mL of each 
dilution was then filtered through a 0.45 µm filter membrane (Millipore, Billerica, MA) 
by vacuum filtration. Filter membranes were placed on 47 mm Difco® Modified mTEC 
agar plates (Becton, Dickinson and Company, Sparks, MD) and incubated at 35 °C for 2 
hours and then 44.5 °C for 24 hours in accordance with EPA Method 1603 (USEPA, 
2002). Following incubation, ten presumed E.coli (magenta) colonies for each of the six 
sampling site sets were randomly selected, transferred to Difco® Tryptic Soy agar 
(Becton, Dickinson and Company, Sparks, MD) using a sterile loop, and incubated at 35 
°C for 24 hours. E. coli cell suspensions were prepared by transferring two colonies of 
each isolate into tubes with 5 mL of BBL® Tryptic Soy Broth (Becton, Dickinson and 
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Company, Sparks, MD) and incubating at 35 °C for 3 hours while shaking at 150 rpm. 
Tubes were checked for turbidity against a pre-prepared 0.5 McFarland standard 
corresponding to a 107 – 108 CFU/mL bacterial cell count in the broth.  
After incubation, sterile swabs were used to inoculate 100 mm Mueller Hinton 
Agar (MHA) plates (Neogen Corporation, Lansing, Michigan). Antibiotic resistance of 
the E. coli isolates was determined by the Kirby-Bauer method for antibiotic 
susceptibility (Bauer et al., 1966) . Eight antibiotic susceptibility discs (Becton, 
Dickinson and Company, Franklin Lakes, NJ) of tetracycline (30 µg), ampicillin (10 µg), 
ciprofloxacin (5 µg), sulfamethoxazole/trimethoprim (23.75/1.25 µg), imipenem (10 µg), 
gentamicin (120 µg), cefoperazone (75 µg), and cephalothin (30 µg) were stamped onto 
each MHA plate using a BBL® Sensi-Disc® 8-place Dispenser (Becton, Dickinson and 
Company, Franklin Lakes, NJ). The MHA plates were then incubated at 35 °C for 16 – 
24 hours and the diameters of the inhibition zones measured to determine resistance, 
intermediate resistance, or susceptibility of each isolate to the antibiotics according the 
Clinical and Laboratory Standards Institute (CLSI) standards. Reference organisms, E. 
coli ATCC 25922, Staphylococcus aureus ATCC 25923, and Pseudomonas aeruginosa 
ATCC 27852 (American Type Culture Collection, Manassas, VA), were used as controls 
to ensure consistency during the antibiotic disc diffusion process. 
It should be noted that for an initial screening sampling event, erythromycin (15 
µg) was used in place of cefoperazone. The replacement of erythromycin with 
cefoperazone as the eighth antimicrobial agent for this study occurred due to 
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inconsistencies in the inhibition zones and the absence of established reference data 
relating to the control organisms for that antibiotic.  
2.4 PCR Isolate Confirmation 
PCR amplification of the E. coli specific uidA sequence was used to confirm all 
isolates collected as E. coli (Bower et al., 2005). Cell suspensions of each presumed E. 
coli isolate were prepared by suspending bacterial lawn growth from the MHA agar in 
100 µL of sterile, distilled water. PCR mixtures (50 µL) were prepared consisting of 25 
µL of GoTaq® G2 Green Master Mix (Promega, Madison, WI), 1.75 µL (350 nM) each 
of the forward (uidA1318F) and reverse (uidA1698R) primers (Integrated DNA 
Technologies, Coralville, IA), 5 µL of cell suspension as the template DNA, and 16.5 µL 
of sterile nuclease-free water. E. coli 25922 isolates were used for the positive control. 
Primer sequences, target, and reference are shown in Table 2. 
 
Table 2: PCR primers for amplification of the E. coli specific uidA gene 
Primer Sequence Target Reference 
uidA1318F 5’CCGATCACCTGTGTCAATGT 3’ 
E.coli β -
glucuronidase 
(Bower et 
al., 2005) 
uidA1698R 5’GTTACCGCCAACGCGCAATA 3’ 
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PCR conditions included 1 initial heating cycle at 94 °C for 4 minutes; followed 
by 35 cycles at 94 °C for 30 seconds, 60 °C for 30 seconds, and 72 °C for 30 seconds; a 
final cycle at 72 °C for 6 minutes, and then held at 4 °C. DNA electrophoresis was 
performed in a 2% agarose gel (Amresco, Solon, OH) stained with ethidium bromide 
(Sigma-Aldrich, St. Louis, MO) and a 1X Tris-Borate-EDTA (TBE) (Fisher 
BioReagents, Fair Lawn, NJ) buffer solution. A 100 bp ExACTGene™ DNA ladder 
(Fisher BioReagents, Fair Lawn, NJ) was used as the marker.  
2.5 Heterotrophic Plate Counts 
Four concentrations of each of the six water samples were prepared (1.0, 0.1, 
0.01, and 0.001) by ten-fold serial dilutions in PBS. Thirty microliters of each dilution 
were spread-plated onto five sets of 47 mm plate Bacto® Reasoner’s 2A (R2A) agar 
(Difco Laboratories, Detroit, MI) amended with the following antibiotics: 32 µg/mL 
ampicillin (Ward’s Science, Rochester, NY), 16 µg/mL tetracycline (Alfa Aesar, Ward 
Hill, MA), 4 µg/mL ciprofloxacin (TCI America, Portland, OR), 50.4 µg/mL 
sulfamethoxazole (Chem-Impex International Inc., Wood Dale, IL), and un-amended 
R2A with no antibiotic. Antibiotic concentrations in the agar were determined based on 
prior studies and are generally around half the strength of either the IV or oral dosage 
concentrations (Pei et al., 2006, Gao et al., 2012, Garcia-Armisen et al., 2013). Plates 
also contained 200 µg/mL of cycloheximide (Amresco, Solon, OH) as a fungicide. All 
plates were incubated at 28 °C for five days before obtaining bacterial CFU plate counts. 
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2.6 Statistics 
E. coli isolate responses to antibiotic susceptibility disc diffusion were 
categorized as either susceptible or resistant (including intermediate resistance) and 
assigned a binary value for each response: 1 for resistant and 0 for susceptible. Isolates 
and isolate responses could then be grouped into a number of various categories and 
tested for significant associations by chi-square analysis. Groupings were generally done 
by pairing binary data from two individual sampling sites or two groups of sampling 
sites, generating two-by-two grids with one degree of freedom. Significant differences 
were determined by Chi square sums of 3.84 or greater, or p < 0.05 for one degree of 
freedom. Statistical analysis of the heterotrophic bacteria and box plot production was 
done using SAS® University Edition (SAS Institute, Cary, NC). Significant differences 
in the abundance and normalized resistance rates of heterotrophic ARB were evaluated 
using one-way ANOVA by least-significant-difference (LSD) comparison. Significant 
differences were checked for homogeneity of variance by Levene’s test, and in cases 
where significant differences in homogeneity were found in the data set significant 
difference was determined by Welch’s ANOVA. Relationships were considered to be 
significant at p < 0.05. 
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3. RESULTS 
 
3.1 PCR Isolate Confirmation 
Isolates were confirmed as E. coli through PCR amplification of uidA with E. 
coli-specific primers and an expected amplicon size of approximately 400 bp (Bower et 
al., 2005). Figure 2 shows the results of PCR amplicon gel electrophoresis of all 300 
isolates. Out of the total 300 isolates collected for this study, 280 (93%) were confirmed 
as E.coli. Any isolate that returned negative results had a second cell suspension 
prepared at a higher concentration, and both the original suspension and concentrated 
suspension were run again to confirm the negative result. Positive and negative controls 
produced the expected results for each assay. Several isolates initially produced negative 
results, but when the additional cell suspension was made and a second reaction was 
performed to confirm the negative results, the isolates returned positive. The 20 isolates 
that were not confirmed were excluded from the results and statistical analysis of the 
study.  
 
  
Figure 2: Results of PCR amplicon gel electrophoresis of uidA (~400 bp) for all 300 E. coli 
isolates obtained from sampling events 1 – 5. Green arrow = positive control, red arrow = 
negative control. 
5 4 3 
2 1 
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3.2 E. coli Isolate Antibiotic Susceptibility  
3.2.1 Individual Antibiotics 
A total of 280 confirmed isolates across all sampling sites and events were tested 
for susceptibility to 8 antibiotics. Inhibition zone diameters were measured and recorded 
in millimeters, and compared to CSLI standards to determine if each isolate was 
susceptible or resistant to each antibiotic. Isolates displaying intermediate resistance 
were categorized as resistant. The number of isolates expressing resistance to individual 
antimicrobial agents by sampling site are displayed in Table 3.  
 
Table 3: Number of E. coli isolates (%) expressing resistance to antibiotics, by sampling site 
Antibiotic Disc ID 
Sampling Site 
Total 
(n=280) 
Upstream of any WWTP Downstream of ≥ 1 WWTP 
1 
(n=49) 
2 
(n=44) 
3 
(n=46) 
4 
(n=47) 
5 
(n=44) 
6 
(n=50) 
Tetracycline  TE-30 2 (4) 4 (9) 0 (0) 8 (17) 10 (23) 14 (28) 38 (14) 
Ampicillin AM-10 3 (6) 1 (2) 6 (13) 8 (17) 9 (20) 14 (28) 41 (15) 
Cefoperazone CFP-75 1 (2) 0 (0) 0 (0) 1 (2) 3 (7) 3 (5) 8 (3) 
Ciprofloxacin CiP-5 0 (0) 0 (0) 0 (0) 2 (4) 3 (7) 7 (14) 12 (4) 
Sulfamethoxazole/
Trimethoprim 
SXT 1 (2) 0 (0) 0 (0) 2 (4) 3 (7) 7 (14) 13 (5) 
Gentamycin GM-10 2 (4) 0 (0) 0 (0) 1 (2) 2 (5) 3 (6) 8 (3) 
Cephalothin CF-30 44 (90) 38 (86) 37 (80) 36 (77) 38 (86) 43 (86) 236 (84) 
Imipenem IPM-10 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
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Only 12% of all isolates were susceptible to all 8 antibiotics. The relatively low 
number of susceptible isolates can mostly be attributed to the high rate of cephalothin 
resistance found across all sampling sites. A large proportion (84%) of all isolates 
expressed resistance or intermediate resistance to cephalothin, with rates of resistance at 
each individual sampling site falling consistently between 77 - 90% of the isolates 
collected. The next highest rates of resistance after cephalothin occurred with respect to 
ampicillin and tetracycline at 15% and 14% of all isolates, respectively. Resistance to 
ampicillin was expressed in 41 isolates, with resistance rates falling between 2 – 13% for 
isolates obtained upstream of WWTP discharges and 17 – 28% for isolates obtained 
downstream of WWTP discharges; and resistance to tetracycline was expressed in 38 
isolates, with resistance rates falling between 0 – 9% for isolates obtained upstream of 
WWTP discharges and 17 – 28% for isolates obtained downstream of WWTP 
discharges. Resistance to cefoperazone, gentamycin, ciprofloxacin, and 
sulfamethoxazole/trimethoprim was found in a fewer number of isolates, at rates of 3%, 
3%, 4%, and 5%, respectively. All four resistances were found more frequently in the 
isolates obtained from downstream sampling sites. Gentamycin resistance was the only 
instance in which isolate resistance was found to occur more frequently in one of the 
upstream sites than in one of the downstream sites (site 1 vs. site 4). All 280 isolates 
were susceptible to imipenem.  
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Figure 3: Percentage of resistant isolate responses to seven of eight antibiotics by sampling site. 
Cephalothin is excluded for visibility of less frequently occurring AB resistances. IPM, imipenem, 
GM, gentamycin, SMX, sulfamethoxazole, CiP, ciprofloxacin, CFP, cefoperazone, AM, ampicillin, 
TE, tetracycline. 
 
A column chart of isolate resistance responses by sampling site and antibiotic 
shows an increase in the rate of resistant responses in the downstream sampling sites 
(Figure 3). Isolates collected from the downstream sampling sites expressed resistance 
more frequently and to a higher variety of antimicrobial agents than the upstream sites. 
Sampling site 1 displays the most diversity in resistance to different agents in the 
upstream group, due to one isolate sampled during event 2 expressing resistance to six 
agents. The number of total resistant responses also appears to increase as the sampling 
sites progress further downstream in the downstream group. Cephalothin resistance is 
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presented separately in Figure 4 as to not visually overwhelm the less frequently 
occurring antibiotic resistances. Cephalothin resistance occurred at a greater frequency 
and more consistently across all sampling sites than the other antibiotic resistances.  
Chi-square analysis was used to determine significant differences in the rates of 
isolate resistance to individual antibiotic agents by location. Sampling sites (independent 
 
 
 
Figure 4: Column chart of cephalothin resistant E. coli isolate responses. Resistance occurred at a 
greater frequency than other antibiotic resistances, more consistently across upstream and 
downstream sampling sites. 
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variable) were tested against each other individually, and also as two major groupings of 
sites: (1) upstream of any WWTP discharge (sites 1 -3) and (2) downstream of at least 
one WWTP discharge (sites 4 -6). Isolate responses to each antibiotic (dependent 
variable) were assigned a binary value, 0 for susceptible and 1 for resistant, and summed 
for each category. A total of eight chi-square tests, one for each of the eight antibiotics 
for which isolate resistance was tested, were performed for each sampling site set.  
Chi-square tests for isolate resistance by individual sampling site (Figure 5) 
showed significant differences (p < 0.05) between at least one pair of sites for ampicillin, 
sulfamethoxazole, tetracycline, and ciprofloxacin. The majority of these occurred 
between site pairings in which one site was upstream of a WWTP and the other site was 
downstream of a WWTP. Only one test reported a significant difference between two 
sites with the same relative location to a WWTP. This result was reported for the rate of 
isolate resistance to tetracycline between sites 2 and 3, corresponding to the Burton 
Creek site upstream of the WWTP and the Carter’s Creek site upstream of its confluence 
with Burton Creek, respectively.  
When sampling sites were categorized into either an upstream (sites 1 – 3) or 
downstream (sites 4 – 6) group, a significant difference (p < 0.05) was found to exist in 
isolate rates of resistance to ampicillin, tetracycline, cefoperazone, ciprofloxacin, and 
sulfamethoxazole. While cefoperazone resistance did not increase significantly between 
any individual sampling sites, there was a significant increase when compared between 
the upstream and downstream groups.  
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Figure 5: Chi-square test values for rates of isolate resistance between all sampling sites by 
antibiotic. A significant difference (p < 0.05) between sites existed for test values > 3.84 (critical 
value for 1 degree of freedom). Values for which one site was upstream and the other was 
downstream are bolded. Shaded cells are tests that reported a significant difference in isolate 
resistance rates for that antibiotic. Cells with no value ( - ) indicate that no isolate resistance 
existed at one of the sites. 
1 2 3 4 5 6 1 2 3 4 5 6
1 0.83 1.33 2.81 4.24 8.33 1 0.91 0.95 0.39 1.29 4.77
2 3.64 5.55 7.22 11.55 2 - 1.91 3.11 6.66
3 0.29 0.89 3.25 3 2.00 3.24 6.95
4 0.18 1.67 4 0.29 2.73
5 0.72 5 1.27
6 6
1 2 3 4 5 6 1 2 3 4 5 6
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5 0.34 5 0.10
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1 0.91 0.95 0.00 1.29 1.00 1 0.26 1.65 3.01 0.26 0.33
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4 1.19 0.92 4 1.43 1.42
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3.2.2 Multi-drug Resistance  
Binomial resistance values determined by the number of resistant responses of 
each isolate were tallied and sorted into five groups, isolates resistant to 0, 1, 2, 3, or ≥ 4 
agents, and organized by sampling site (Table 4). Out of the 280 isolates, the majority 
(88%) showed resistance to at least 1 antibiotic agent. A total of 28 isolates (10% of 
total) showed resistance to 2 agents, 9 (3% of total) showed resistance to 3 agents, and 
17 (6% of total) showed resistance to 4 or more agents. Of the 54 multi-drug resistant 
isolates collected (resistant to at least 2 agents), 41 (76%) were obtained from 
downstream sites (sites 4 -6). All isolates resistant to 3 agents and all but one of the 
isolates that were resistant to 4 agents were collected from one of the downstream sites.  
 
Table 4: Number (%) of multi-drug resistant E. coli isolates by sampling site 
Site 
Number 
Number (% by site) of Isolates with Resistance to n agents: 
Total 
n = 0 n = 1 n = 2  n = 3 n ≥ 4 
1  5 (10) 39 (80) 4 (8) 0 (0) 1 (2) 49 
2  5 (11) 35 (80) 4 (9) 0 (0) 0 (0) 44 
3  7 (15) 35 (76) 4 (9) 0 (0) 0 (0) 46 
4  8 (17) 29 (62) 5 (11) 2 (4) 3 (6) 47 
5  6 (14) 24 (55) 6 (14) 3 (7) 5 (11) 44 
6  2 (4) 31 (62) 5 (10) 4 (8) 8 (16) 50 
All Sites 33 (12) 193 (69) 28 (10) 9 (3) 17 (6) 280 
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Resistance responses were also sorted by type of antibiotic and number of agents 
that each isolate was resistant to (Table 5). Cephalothin resistance was again the most 
frequently occurring (95%) antibiotic resistance in the sample set of multi-drug resistant 
isolates (resistant to 2 or more agents). Out of all isolates that were resistant to at least 
one antibiotic, 74% were only resistant to cephalothin, and cephalothin resistance 
accounted for 95% of all single-drug resistant isolates. Isolates only resistant to 
tetracycline, ampicillin, or cefoperazone were found sparingly, each representing less 
than 2% of the single-drug resistant isolates.  No isolates were only resistant to 
ciprofloxacin, sulfamethoxazole, gentamycin, or imipenem.  
Isolates resistant to 2 or more agents were generally resistant to cephalothin and 
either tetracycline (41%), or ampicillin (48%). Resistance to 3 agents occurred less 
frequently than resistance to 4 or more agents, at only 4% of resistant isolates. All 
isolates showing resistance to 4 or more antibiotics were resistant to cephalothin, and 
over 80% of these isolates were also resistant to tetracycline, and 90% to ampicillin. 
Sulfamethoxazole resistance was only found in isolates resistant to 3 or more agents. 
Resistance to cefoperazone, ciprofloxacin, sulfamethoxazole, and gentamycin was 
generally accompanied by several other resistances.  
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Table 5: Number of E. coli isolates expressing resistance to each antibiotic, grouped by the number 
of agents the isolate was resistant to 
Antibiotic 
Number (%) of Resistant Isolates when Isolate is 
Resistant to n agents: Total 
n = 1 n = 2 n = 3 n ≥ 4 
Tetracycline  4 (2) 12 (41) 8 (89) 14 (82) 38 (15) 
Ampicillin 3 (1.5) 14 (48) 8 (89) 16 (94) 41 (17) 
Cefoperazone 1 (0.5) 0 (0) 0 (0) 7 (41) 8 (3) 
Ciprofloxacin 0 (0) 2 (7) 0 (0) 10 (59) 12 (5) 
Sulfamethoxazole/Tri
methoprim 
0 (0) 0 (0) 3 (33) 13 (76) 13 (5) 
Gentamycin 0 (0) 1 (3) 1 (11) 6 (35) 8 (3) 
Cephalothin 184 (95) 28 (97) 7 (78) 17 (100) 236 (95) 
Imipenem 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
 
 
Chi-square analysis was performed for E. coli isolate multidrug resistance to 
examine any significant associations (p < 0.05) between all individual sampling sites, 
between the two groups of sampling sites representing creek stem regions upstream and 
downstream of the WWTPs, and for each individual sampling site when compared 
against all other sampling sites. Three separate definitions of multidrug resistance were 
examined for each grouping: isolates resistant to 2 or more agents, 3 or more agents, and 
4 or more agents.  
Significant associations were found between several sampling site pairings for all 
classifications of multi-drug resistance (Figure 6). All significant associations between 
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individual sampling sites and rates of multi-drug resistance occurred between upstream 
and downstream sites; none were found between sites within the same upstream or 
downstream group.  
 
 
Figure 6: Chi-square test values for rates of isolate resistance between all sampling sites by extent of 
multi-drug resistance. A significant difference (p < 0.05) between sites existed for test values > 3.84 
(critical value for 1 degree of freedom). Values for which one site was upstream and the other was 
downstream are bolded. Shaded cells are tests that reported a significant difference in multi-drug 
resistance rates for that site pairing. Cells with no value ( - ) indicate that no multi-drug resistance 
occurred at one of the sites.  
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A significant association (p < 0.001) was found to exist between the number of 
isolates expressing resistance to ≥ 2, ≥ 3, and ≥ 4 antibiotic agents and whether the 
isolate was collected upstream of any WWTP (sites 1, 2, and 3) vs. downstream of at 
least 1 WWTP (sites 4, 5, and 6). There was not a significant association (p > 0.05) 
between the upstream and downstream sample site groups and the occurrence of isolate 
resistance to 1 or more agents (data not shown). 
Six chi-square tests were performed to compare rates of multi-drug resistance 
isolates between each individual sampling site and all other five sites for isolates 
resistant to 2 or more, 3 or more, or 4 or more antibiotic agents (Table 6); and between 
each individual sampling event and all other five events for isolates resistant to 2 or 
more, 3 or more, or 4 or more antibiotic agents (Table 7).  These tests are intended to 
provide information concerning which sites or sampling events are contributing the most 
significance to variations in the antibiotic resistance profiles of surface water E. coli in 
the watershed, independent of whether the site is contributing significantly less or 
significantly more resistant isolates compared to the other sampling sites. Ideally, all of 
these tests would not have a significant association with the data set, indicating that the 
overall trend in multi-drug resistance is not significantly affected by only one single 
sampling event. 
Table 6 shows sites that were identified as having a significant association with 
the number of multi-resistant isolates produced when compared against all other 
sampling sites and the p-values of each association. Downstream sampling sites 5 and 6 
contributed significantly to the variation between sites in the amount of isolates resistant 
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to ≥ 2 and ≥ 3 antibiotic agents, with site 6 contributing significantly to variations 
between sites with isolates resistant to ≥ 4 agents as well. Upstream of the WWTPs, sites 
2 and 3 showed a significant difference in the numbers of isolates resistant to ≥ 3 agents. 
Of all the sampling events and for all definitions of multi-drug resistant isolates, only 
sampling event 2 had a significant (p < 0.01) difference for the number of isolates 
resistant to 2 or more antibiotics (Table 7). Ideally, all of these tests would not have a 
significant association with the data set, indicating that the overall trend in multi-drug 
resistance is not significantly affected by only one single sampling event. 
 
Table 6: Chi-square significant associations for individual sampling sites for 3 groupings of 
multidrug E. coli isolate resistance. Shaded cells are site/multidrug combinations producing a 
significant association, df =1 
 
Site Number 
p values for sites with a significant association with 
respect to isolates resistant to n agents: 
n ≥ 2 n ≥ 3 n ≥ 4  
1 p > 0.05 p > 0.05 p > 0.15  
2 p > 0.05 p < 0.025  p > 0.05 
3 p < 0.05 p < 0.02 p > 0.05  
4 p > 0.25 p > 0.25 p > 0.25  
5 p < 0.025 p < 0.05 p > 0.10  
6 p < 0.005 p < 0.0005 p < 0.0025 
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Table 7: Chi-square significant associations for sampling events for 3 groupings of multidrug E. coli 
isolate resistance. Shaded cells are site/multidrug combinations producing a significant association, 
df =1 
 
 
 
 
 
 
 
 
3.3 Heterotrophic Plate Counts 
Heterotrophic bacterial plate counts were obtained during six sampling events in 
order to examine the antibiotic resistance profiles of the cultivable, heterotrophic 
bacterial community in the watershed. The log-transformed bacterial concentrations of 
each treatment category for all sampling events and sampling sites are displayed in Table 
8. The limit of detection was one CFU in 30 µL of undiluted sample, or 1.52 log10 
CFU/mL. There were five instances in which no bacteria were culturable within the 
sample volume and concentration limit; four of the ciprofloxacin-amended plates, and 
one of the tetracycline-amended plates. These results were reported as below the limit of 
detection, and were represented as ½ the limit of detection (16.67 CFU/mL) for 
statistical analysis. 
  
Event Number 
p values for events with a significant association with 
respect to isolates resistant to n agents: 
n ≥ 2 n ≥ 3 n ≥ 4 
1 p < 0.01 p > 0.25 p > 0.25 
2 p > 0.25 p > 0.25 p > 0.25 
3 p > 0.25 p > 0.25 p > 0.25 
4 p > 0.25 p > 0.25 p > 0.25 
5 p > 0.15 p > 0.25 p > 0.25 
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Table 8: Log10-transformed concentrations (log10 CFU/mL) of heterotrophic bacteria and antibiotic 
resistant heterotrophic bacteria for each antibiotic by sampling event and sampling site. AM, 
ampicillin, CiP, ciprofloxacin, TE, tetracycline, SMX, sulfamethoxazole 
 
  
Sampling 
Event 
Date AB 
Concentration (log10 CFU/mL) by Sampling Site 
1 2 3 4 5 6 
#1 7/13/2015 
None 3.05 6.08 3.52 5.28 4.78 4.21 
AM 2.67 3.22 3.03 4.20 3.85 2.70 
CiP < 1.52 2.12 1.52 2.52 2.52 2.12 
TE 1.82 < 1.52 2.52 3.82 3.10 2.12 
SMX 2.88 3.88 2.82 4.29 3.70 3.15 
#2 9/7/2015 
None 5.10 5.29 4.59 5.41 5.23 5.43 
AM 3.52 3.70 3.29 4.04 3.90 3.65 
CiP 3.82 3.70 3.75 4.11 4.18 4.26 
TE 2.52 2.90 2.22 3.47 2.90 2.87 
SMX 3.88 4.18 3.53 4.70 4.32 4.52 
#3 11/5/2015 
None 4.32 4.46 4.29 5.17 4.59 5.17 
AM 2.82 3.17 2.85 3.56 3.85 3.56 
CiP 3.56 3.48 3.59 3.94 4.08 3.94 
TE 2.52 2.52 2.37 2.87 3.22 2.87 
SMX 4.12 3.87 3.64 4.66 4.19 4.66 
#4 1/20/2016 
None 5.17 5.50 5.05 5.21 5.17 5.20 
AM 2.70 4.37 2.94 3.99 4.00 3.64 
CiP 3.32 3.78 3.69 3.46 3.72 3.50 
TE 1.52 2.85 1.82 3.18 3.11 2.67 
SMX 3.34 2.85 3.43 4.56 4.73 4.48 
#5 2/16/2016 
None 5.04 5.16 4.58 5.30 5.27 5.41 
AM 2.37 4.04 2.12 4.22 4.17 3.77 
CiP < 1.52 1.82 < 1.52 3.79 2.88 2.97 
TE 2.43 2.92 2.56 3.64 3.65 3.48 
SMX 3.99 4.52 3.22 5.20 4.85 4.43 
#6 4/6/2016 
None 4.70 5.09 4.17 5.65 5.39 5.39 
AM 3.22 3.43 3.11 4.41 4.41 4.03 
CiP 1.52 2.22 < 1.52 3.90 3.87 3.21 
TE 3.56 3.15 3.17 3.95 3.92 3.95 
SMX 2.90 3.52 2.43 4.95 4.64 4.01 
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3.3.1 Abundance of Antibiotic Resistant Bacteria in Heterotrophic Bacteria Populations 
For the total concentrations of each subset of heterotrophic bacteria cultivations, 
the R2A agar with no antibiotic produced the highest overall concentration with a 
median value of 1.47 × 105 CFU/mL and a mean value of 1.68 × 105 CFU/mL (Figure 
7). Sulfamethoxazole resistant bacteria were the next highest with a median 
concentration of 1.18 × 104 CFU/mL, followed by ampicillin and ciprofloxacin with 
median concentrations of 4.00 × 103 CFU/mL and 3.10 × 103 CFU/mL, respectively. 
Tetracycline resistant heterotrophic bacteria had the lowest overall concentration in the 
study area with a median concentration of 7.67 × 102 CFU/mL. Variance in the total 
population for each treatment was considerably large, with standard deviations larger 
than the mean values. 
 
 
Figure 7: Box plot of log-transformed concentration distributions (log10 CFU/mL) of heterotrophic 
bacteria by antibiotic agent across all sampling events and sampling sites.  
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Concentrations of bacteria in the R2A treatment with no antibiotic were 
relatively consistent with the exception of a few outliers (Figure 8), in the case of 
sampling site 1 falling two orders of magnitude below the median value. Concentrations 
in the sample set varied significantly across sampling sites (p < 0.025) and between 
upstream (sites 1 -3) and downstream (sites 4 – 6) site groups relative to WWTP 
discharge (p < 0.02), but not by sampling event (p > 0.15). Median concentrations were 
near or above 1 × 105 CFUs/mL, except for site 3. 
 
 
Figure 8: Box plot for total heterotrophic bacteria concentrations (log10 CFU/mL) in the control 
group (un-amended R2A media) across sampling sites for all sampling events 
 
 34 
 
 
Abundance of ampicillin-resistant bacteria varied significantly between sampling 
sites (p < 0.0001), primarily due to the variance occurring between sites 1, 2, 3, and 6 
and sites 4 and 5 (Figure 9).  There was no temporal effect on the occurrence of 
ampicillin-resistant bacteria, and CFUs observed on R2A plates did not vary 
significantly by sampling event (p > 0.65). Ampicillin resistant bacteria were found in 
significantly greater (p < 0.0001) concentrations in the downstream group relative to 
WWTP discharge, with mean concentrations of 1.3 × 104 and 1.2 × 104 CFU/mL from 
sites 4 and 5, respectively.  
 
 
Figure 9: Concentrations (log10 CFU/mL) of ampicillin-resistant heterotrophic bacteria across 
sampling sites for all sampling events 
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Concentrations of ciprofloxacin resistant bacteria were more broadly distributed, 
with several sites having a range of over two orders of magnitude across all sampling 
events with mean concentrations ranging from 2.07 × 103 to 6.79 × 103 CFU/mL (Figure 
10). Ciprofloxacin resistant bacteria were also considerably less abundant. Minimum 
concentration values for the data set fell below 102 CFU/mL for half of the sampling 
events, and 4 of the 5 results that were below the limit of detection came from 
ciprofloxacin-amended R2A agar. There was a significant variation (p < 0.0001) in the 
abundance of ciprofloxacin resistant bacteria between sampling events, but no 
significance differences in concentrations between the individual sampling sites (p > 
0.10). However, despite generally low abundance and spatial variation between sites, a 
significant difference was also determined to exist between sites when sites were 
grouped by their position relative to WWTP discharge for ciprofloxacin resistant 
bacteria (p < 0.01).  
 
 
 36 
 
 
Figure 10: Concentrations (log10 CFU/mL) of ciprofloxacin-resistant heterotrophic bacteria across 
sampling sites for all sampling events 
 
 
Figure 11: Concentrations (log10 CFU/mL) of tetracycline-resistant heterotrophic bacteria across 
sampling sites for all sampling events 
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Figure 12: Concentrations (log10 CFU/mL) of sulfamethoxazole-resistant heterotrophic bacteria 
across sampling sites for all sampling events 
 
Tetracycline resistance in heterotrophic bacteria produced a few outliers due to 
an atypically compact distribution of concentrations at site 2 (Figure 11), in contrast to 
an otherwise expansive distribution and large standard deviations as seen in the other 
treatments. Standard deviations of resistant bacteria concentrations in the tetracycline 
treatment at sites 2 and 3 were one order of magnitude or more lower than what was 
typically seen in other treatments. The abundance of tetracycline resistant bacteria varied 
significantly by sampling site (p < 0.007) and sampling event (p < 0.02), mainly due to 
considerably higher concentrations sampled during event 6. 
Sulfamethoxazole resistant bacteria were the most prominent across all sampling 
sites in this study with the highest mean concentration of resistant bacteria at any 
sampling site of 6.67 × 104 CFU/mL (Figure 12).  Sampling site had a significant 
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influence (p < 0.0001) on the concentration of resistant bacteria, mainly due to 
consistently higher concentrations found at sites downstream from WWTPs. Temporal 
variations by sampling event did not significantly affect results (p > 0.20). 
The mean concentrations of resistant bacteria obtained upstream of a WWTP in 
the tetracycline and sulfamethoxazole treatments were an order of magnitude below the 
mean concentrations in their respective downstream sites. Significant differences in the 
abundance of ARB were found to exist between upstream and downstream sites for both 
the tetracycline (p < 0.0001) and sulfamethoxazole treatments (p < 0.0001). 
3.3.2 Antibiotic Resistant Bacteria Normalized to Total Heterotrophic Population 
Heterotrophic bacteria populations are diverse and possess a considerable amount 
of intrinsic variance in the way they occur and interact in the environment. By 
normalizing the abundance of antibiotic resistant heterotrophic bacteria in the study area 
to the total heterotrophic bacteria population, a better understanding can be formed 
concerning the extent of antibiotic resistance relative to total numbers. Figure 13 shows 
log-transformed ratios of resistant bacteria CFUs normalized to total HPCs with no 
antibiotic. One-way ANOVA and LSD tests were conducted to determine significance 
between normalized resistance rates and sampling site, sampling event, and relative 
position up or downstream of a WWTP.  
In contrast to the results of the total abundance of heterotrophic ARBs, there 
were no significant (p > 0.05) spatial associations for the ratios of resistant bacteria 
normalized to total HPCs. Sampling site and relative location to a WWTP had no 
significant effect on the proportion of resistant bacteria in each treatment population. 
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While sampling event did have a significant effect on the normalized ratios of 
tetracycline and ciprofloxacin resistant bacteria within the total heterotrophic community 
(p < 0.05), no other significance existed for the other two antibiotics, or for any 
influence between sampling site or relative location to WWTP discharge.  
While there were no significant differences within each treatment group, there 
were differences between the proportions of the different ARB within the total HPC 
population. Though no significant association existed between normalized 
sulfamethoxazole ratios by site, event, or relative location to a WWTP, 
sulfamethoxazole ratios in the total heterotrophic community were significantly higher 
than all of the resistant bacteria ratios for tetracycline, ampicillin, and ciprofloxacin (p < 
0.001). 
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Figure 13: Normalized ratios of the concentrations of antibiotic resistance bacteria to the total 
heterotrophic population for four antibiotics across six sampling sites. 
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4. DISCUSSION 
 
4.1 Antibiotic Resistance in E. coli Isolates  
Ampicillin, sulfamethoxazole, and ciprofloxacin, or closely related drugs 
(amoxicillin), are among the top 5 antibiotics prescribed for use for adults in the U.S. 
(Shapiro et al., 2013, Van Boeckel et al., 2014, Hicks et al., 2015), and all have been 
found to occur in WWTPs in varying concentrations and design conditions (Batt et al., 
2007). In the current study, a significant association (p < 0.05) was found to exist 
between the location of sampling sites relative to WWTPs (upstream group vs. 
downstream group) and isolates expressing resistance to ampicillin, ciprofloxacin, 
cefoperazone, sulfamethoxazole, and tetracycline. This lends support to the hypothesis 
that WWTP effluent may be contributing to the conveyance of antibiotic resistance 
bacteria downstream from discharge points. The absence of significant associations 
between rates of isolate resistance among upstream sites indicates that these differences 
are not solely dependent on variations between all sampling sites, but also their relative 
position to WWTP discharge points. Only one significant difference was found within 
the upstream group, between sites 2 and 3, on two separate streams. 
The occurrence of antibiotic resistance may not always imply an outside effect, 
and can be an intrinsic property of the natural environment. In this study, cephalothin 
represented the highest rate (84%) of resistance found in all isolates. The high rate of 
resistance to cephalothin and the uniformity with which it is expressed across all 
sampling sites suggests that this resistance trait is naturally occurring in the watershed. 
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This is remarkably consistent with results attained in other studies performed with E. 
coli isolates obtained from surface waters in Michigan and Illinois, finding rates of 
isolate resistance to cephalothin at 80.6% and 80% (Sayah et al., 2005, Janezic et al., 
2013). Cephalothin resistance also represented 95% of the 193 isolates resistant to only 1 
antibiotic, dramatically inflating the abundance of isolates classified as resistant to at 
least 1 antibiotic. If cephalothin was excluded from the antibiogram for this study, an 
additional 184 isolates (66% of total) would be classified as susceptible to all agents. 
The rate of isolate resistance to tetracycline (14% of all isolates) was found to be 
lower than expected when compared to similar research. Previous studies have found the 
occurrence of tetracycline resistance to be prevalent in watersheds associated with 
agricultural and animal feed lot operations (Jindal et al., 2006, Rajić et al., 2006), with 
resistance rates of over 90% found in E. coli isolates obtained from swine lagoon 
effluent (Brooks & McLaughlin, 2009). One study, also conducted in the Carter’s Creek 
watershed in College Station, TX, found a substantial occurrence of tetracycline resistant 
bacteria and tetracycline resistant genes in sediment and surface water samples collected 
from the watershed; however, the majority were found in greater abundance bound in 
stream sediment samples than in surface water samples (Sullivan & Karthikeyan, 2012). 
In contradiction with the results of this study, Sullivan &  Karthikeyan (2012) also found 
that while the occurrence of tetracycline resistance genes increased downstream of 
WWTPs, concentrations of tetracycline resistant bacteria were not significantly affected. 
However, this study used a different cultivation media and a different method for 
determining resistance rates, and investigated a more diverse microbial population. It is 
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possible that the effect of WWTP discharge on tetracycline resistance rates in E. coli 
isolates does not occur in the same manner for a more diverse population. Additionally, 
cultivation viability and antibiotic resistance fractions have been shown to be 
significantly influenced by media selection and conditions (Oh et al., 2009). 
Imipenem is a group 2 carbapenem generally reserved as a last line of defense 
against particularly resilient Gram-negative pathogens (Nicolau et al., 2012). As a result 
the agent is prescribed sparingly and resistance to the agent would not be expected to 
develop in the microbial population sampled in this study. Accordingly, out of all the 
isolates collected from all sampling sites, all 280 were susceptible to imipenem. 
Imipenem resistance does not appear to be occurring in the surface water bacteria of the 
Carter’s Creek watershed. 
Overall, the significant increase in the rates of AB resistance to agents associated 
with frequent human use suggests that there is a human influence on the resistance rates 
of surface water bacteria moving downstream through B/CS. While more precise 
investigation into possible sources and sinks for ARBs and ARGs in the watershed is 
needed to confirm major causes, it seems likely that WWTP discharge may be 
contributing to some degree. 
4.2 Multi-drug Resistance in E. coli Isolates  
A substantial fraction (19%) of all 280 E. coli isolates expressed resistance to 2 
or more antibiotics. Multi-drug resistance was found to increase significantly (p < 0.05) 
in the sites downstream of a WWTP for isolates resistant to ≥ 2, ≥ 3, and ≥ 4 agents. 
Other studies have observed high rates in the development of multi-drug resistance in E. 
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coli isolates in WWTP processes (Korzeniewska et al., 2013, Amador et al., 2015), 
found to be primarily driven by the transfer of conjugative plasmids (Silva et al., 2006). 
A number of WWTP disinfection practices have been shown to have negligible effects 
on reducing rates of multi-drug resistant bacteria, and in a number of cases increasing it 
(Bouki et al., 2013). Even if the effluent of the WWTPs in this study area does have 
considerably low levels of multi-drug resistant bacteria, these low concentrations have 
been shown in other studies to persist and propagate through the environment once 
discharged. ARGs not necessarily bound to culturable organisms are also likely escaping 
treatment processes and contributing to the development of multidrug resistance 
(Kümmerer, 2009). Resistance to cefoperazone, sulfamethoxazole, ciprofloxacin, and 
gentamycin was more frequently found in multi-drug resistant isolates, and rarely as the 
only type of resistance. This suggests that resistance to these agents is either driven by 
similar modes of defense coded by resistance genes to other agents, or that the 
acquisition of resistance to these agents usually occurs in tandem with other antibiotic 
resistances.  
The high rates of resistance to cephalothin across all 6 sampling sites inflated 
multi-drug resistance rates, present in 95% of the 248 isolates resistant to at least 1 
antibiotic. This increases the importance of the multi-drug resistance classifications of 
isolates resistant to 3 or more and 4 or more agents, due to cephalothin resistance 
effectively acting as a resistance baseline for this sample set. While the strictest 
definition for multi-drug resistance is resistant to one or more agents, ‘resistance to three 
or more classes’ has become increasingly standard for defining multi-drug resistance in 
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Gram-positive and Gram-negative bacteria (Magiorakos et al., 2012). Still, a substantial 
number, 9% of all 280 isolates, expressed resistance to at least 3 antibiotics. This rate is 
more in line with other reports of the prevalence of multi-drug resistant E. coli in surface 
waters (Blaak et al., 2015), though these rates likely differ considerably as a function of 
antibiotics tested and sampling site. A large majority (86%) of these isolates were 
collected downstream of a WWTP, and all significant increases in rates of isolate 
resistance to 3 or more agents occurred when comparing an upstream site to a 
downstream site. While some degree of multidrug resistance appears to exist naturally, 
the results suggest that WWTPs in the study area are contributing significantly to multi-
drug resistant bacteria in the surface water.  
4.3 Antibiotic Resistance in Total Heterotrophic Bacteria Populations 
A significant increase in the concentrations of antibiotic resistant bacteria 
downstream of WWTP discharge was found for all four agents tested in the total 
heterotrophic bacterial community. Heterotrophic bacteria populations are diverse and 
possess a considerable amount of intrinsic variance in the way they occur and interact in 
the environment (Garcia-Armisen et al., 2013). By normalizing the abundance of 
antibiotic resistant heterotrophic bacteria in the study area to the total heterotrophic 
bacteria population, a better understanding can be made concerning the extent of 
antibiotic resistance relative to total numbers. Unfortunately, this diversity also makes it 
difficult to establish a reliable standard for which to compare resistance rates against. 
Concentrations of ampicillin, ciprofloxacin, and tetracycline resistant bacteria were 
generally confined to a range of 1% to 10% of the total heterotrophic community when 
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compared to the control, though in some instances spiking to between 20% and 40% of 
the total population. However, these large spikes in the ratios of resistant bacteria to the 
control CFU were generally due to significantly lower counts in the control during a 
sampling event or at a sampling site and not because the relative CFU of resistant 
bacteria increased. In contrast, sulfamethoxazole resistant bacteria were frequently found 
to represent from 20% to 80% of the total heterotrophic population, ratios significantly 
(p < 0.001) higher than all other resistant bacteria. This same trend in sulfamethoxazole 
resistant bacteria was found to exist throughout numerous processes sampled in a 
municipal wastewater treatment plant (Gao et al., 2012), also finding that while the total 
abundance of resistant bacteria were reduced in the effluent, that reduction was 
consistent with the reduction in total HPC populations. The similarities in heterotrophic 
sulfamethoxazole resistance observed in the downstream sites in this study may indicate 
contribution of resistance traits originating from WWTP effluent. 
The occurrence of a significant increase in the concentrations of tetracycline 
resistant bacteria downstream of WWTPs in the total heterotrophic populations appears 
to contradict the findings of Sullivan &  Karthikeyan (2012), research also conducted in 
the Carter’s Creek watershed. Sullivan &  Karthikeyan (2012) found no effect of WWTP 
location on the prevalence of tetracycline resistant bacteria in surface water, but did see 
an increase in the abundance of tetracycline ARGs. While molar concentrations of 
tetracycline used in both studies were similar, the discrepancy might be explained by 
differences in the cultivation media: Sullivan &  Karthikeyan (2012) used nutrient-rich 
agar and this study used nutrient-limited R2A agar. Differences in cultivation media can 
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significantly affect the counts of culturable ARB even from identical samples (Garcia-
Armisen et al., 2013). Sullivan &  Karthikeyan (2012) also found no seasonal variability 
in the occurrence of tetracycline resistant genes or bacteria. While there were significant 
variations in the abundance and normalized rates of tetracycline and ciprofloxacin 
resistant heterotrophic bacteria found in this study, the variations did not appear to be 
related to seasonal changes, and are likely due to natural occurrence of variance in the 
environment.  
While there was a significant increase in the abundance of AB resistant bacteria 
in the downstream sites, there was no significant increase when the concentrations were 
normalized to total HPCs with no antibiotic in the cultivation media. This indicates that 
while the total amount of resistant bacteria is increasing downstream through the 
watershed, it is increasing proportionately with the total population. This could be 
explained in a number of ways. WWTP effluent may be introducing viable bacteria back 
into the watershed that has experienced no significant increase in its proportion of 
resistant bacteria, increasing total abundance without increasing normalized rates of 
resistance. Constituents of the effluent, residual suspended solids and dissolved 
nutrients, may also be facilitating increased growth rates of the pre-existing 
heterotrophic bacteria in the downstream surface water. With more favorable growth 
conditions, the total heterotrophic population, and the abundance of resistant bacteria, 
increases proportionately.  
The characteristic diversity of heterotrophic bacteria and the natural variance in 
environmental resistance profiles perhaps contributes to overwhelming any 
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anthropogenic trends that might exist. Total heterotrophic population CFUs on control 
plates during antimicrobial studies can vary dramatically (3 orders of magnitude) (Pei et 
al., 2006), making it difficult to normalize results of antibiotic bacteria within the 
population.  
4.4 Temporal Considerations 
While not a central focus of this study, variations in rates of individual 
antimicrobial agent resistance and multi-drug resistance also occurred due to temporal 
variations between sampling events. Several significant associations (p < 0.05) existed 
between the abundance and normalized rates of HPC resistance. Chi-square tests on 
individual sampling events indicated one sampling event (event 2) that had a significant 
correlation (p < 0.0005) with the rates of multi-drug resistant E. coli isolates. Ideally, all 
of these tests would not have a significant association with the data set, indicating that 
the overall trend in multi-drug resistance is not significantly affected by only one single 
sampling event.  
These variations can be mitigated through more stringent control of 
environmental conditions or, more realistically, by increasing the isolate sample size so 
that the impact of one outlying data set is reduced. Increased rates of antibiotic resistance 
might be triggered by sewage line leaks or other independent events that introduce an 
additional source of bacteria into the water, though no significant irregularities in 
bacterial plate counts were observed in this study. It is also possible that a relationship 
exists between the prevalence of isolate antibiotic resistance and temporal variance 
related to changes in season, stream flow, local population, or WWTP operations. More 
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research tied to these variables would need to be done to determine the impact of 
temporal and seasonal variations on the resistance profiles of surface water bacteria.   
4.5 Significance of Cultivation-Based Approach 
The scope of this project was limited to only cultivable bacteria, and therefore 
does not completely represent the entire microbial community as viable-but-not-
culturable (VBNC) bacteria have not been considered. Cultivable populations may only 
represent a small portion of the entire microbial community (Smit et al., 2001), and it 
has been shown that variability in the microbial community in response to the presence 
of various antibiotics can be exaggerated when evaluated by cultivation-based methods 
(Garcia-Armisen et al., 2013). Further, cultivation viability and antibiotic resistance 
fractions have been shown to be influenced by media selection and conditions, and a 
fully standardized method may still need to be developed for consistent results between 
studies (Oh et al., 2009). While many studies are now being conducted to evaluate 
ARGs by molecular methods, developing cultivation-based methods for the analysis of 
antimicrobial resistance in the environment is critically important. Cultivation-based 
methods demonstrate the phenotypic expression of the ARGs present, and provide the 
benefit of showing actual outcome over potential outcomes. They may also be preferred 
in cases where the resources available to an agency justifies the use of cultivation-based 
methods.  
4.6 Mitigation and Prevention 
While an understanding of the role that WWTPs play in the conveyance of 
antibiotic resistance through the environment is important for developing effective 
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management practices, domestic mitigation of antibiotic resistance is unlikely to be the 
key limiting factor in the proliferation of ARB. The overuse and application of 
antibiotics in industrializing nations with relaxed or non-existent regulation may 
ultimately prove to have a much more significant impact concerning the development of 
antibiotic resistance on a global scale (Istúriz & Carbon, 2000). Most serious 
conversations about controlling the spread of AB resistance center around limiting use 
and proper clinical procedures to prevent multi-drug resistant bacteria from ever 
developing in the first place (Stephan & Matthew, 2005). International efforts are being 
made to identify critical priorities for stable control of AB resistance, and to promote 
urgent mitigation actions including public education, improvements in sanitation and 
public health, limitations on use, old and new antibiotics, and alternative non-antibiotic 
disease prevention measures (Bush et al., 2011).  
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5. CONCLUSIONS 
 
The goal of this study was to investigate the relationship between human activity 
and urbanization on the occurrence of antibiotic resistance in the surrounding watershed 
using cultivation-based methods. The results suggest that the effects of human activity 
and development, specifically by the introduction of treated WWTP effluent into local 
surface waters, are potentially significant contributors to the spread and persistence of 
antibiotic resistance in nearby surface water environments.  
The relative location of sampling points up or downstream of a WWTP discharge 
point had a significant effect on the concentration of antibiotic resistant E. coli isolates 
that were observed from that site. Downstream isolates showed an increased resistance 
to ampicillin, ciprofloxacin, cefoperazone, sulfamethoxazole, and tetracycline, and were 
more often resistant to a higher quantity of different antibiotics. These effects were 
mirrored in the total heterotrophic bacteria community, with a significant increase in the 
abundance of ampicillin, ciprofloxacin, sulfamethoxazole, and tetracycline resistant 
bacteria in the surface water downstream of WWTP discharge points. However, when 
normalized to total HPCs, this significance did not persist; the inherent diversity of 
heterotrophic communities may encourage antibiotic resistance profiles that are more 
resilient to variations in the environment and overshadow some anthropogenic 
influences. Particulate and nutrient constituents of the WWTP effluent may also be 
facilitating enhanced growth conditions for heterotrophic populations preexisting in the 
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environment, producing proportional increases in abundance of both resistant and total 
bacteria. 
More research needs to be conducted concerning the transport and storage of 
microbial antibiotic resistance in the environment. Resistance profiles may vary 
considerably between surface water and sediment-bound bacteria. Further understanding 
of the interrelationships between ARB concentrations, ARG concentrations, antibiotic 
agents, microbial species, and environmental media will help to eventually enable the 
modeling of antibiotic resistance transfer through the environment. Standardization of 
techniques to evaluate antibiotic resistance in the environment may be beneficial in 
elucidating these mechanisms, as the extent of resistance has been shown to vary 
dramatically in relation to cultivation media and sampling site selection even within the 
same watershed.  
The results do not conclusively identify WWTP discharge as the cause of the 
increased rates of resistance; there are many factors that could be contributing to the 
trends seen in the data. A more specific investigation and more constrained system 
focusing on the inflows, outflows, and process components at the WWTPs would be 
beneficial in further determining the extent of its contribution to resistance in the 
environment. The larger scale watershed approach is still important, as measurements at 
the outflow may be artificially lowered by downstream reactivation of bacteria initially 
neutralized during UV treatment. A broader picture can be drawn of occurrence of 
resistance in the environment by looking at resistance trends across the watershed, 
informing further investigation into more precise contributors.  
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